These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 30706425
1. L-Ornithine L-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses. Butterworth RF, McPhail MJW. Drugs; 2019 Feb; 79(Suppl 1):31-37. PubMed ID: 30706425 [Abstract] [Full Text] [Related]
2. Efficacy of L-ornithine L-aspartate for minimal hepatic encephalopathy in patients with cirrhosis: A meta-analysis of randomized controlled trials. He Q, Mao C, Chen Z, Zeng Y, Deng Y, Hu R. Arab J Gastroenterol; 2024 May; 25(2):84-92. PubMed ID: 38403493 [Abstract] [Full Text] [Related]
3. Beneficial effects of L-ornithine L-aspartate for prevention of overt hepatic encephalopathy in patients with cirrhosis: a systematic review with meta-analysis. Butterworth RF. Metab Brain Dis; 2020 Jan; 35(1):75-81. PubMed ID: 31338724 [Abstract] [Full Text] [Related]
13. A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis. Schmid M, Peck-Radosavljevic M, König F, Mittermaier C, Gangl A, Ferenci P. Liver Int; 2010 Apr 24; 30(4):574-82. PubMed ID: 20456040 [Abstract] [Full Text] [Related]
15. Efficacy of different drugs in the treatment of minimal hepatic encephalopathy: A network meta-analysis involving 826 patients based on 10 randomized controlled trials. Cai XJ, Wang L, Hu CM. J Cell Biochem; 2018 Nov 24; 119(10):8336-8345. PubMed ID: 29932239 [Abstract] [Full Text] [Related]
16. Pharmacokinetic and Pharmacodynamic Properties of L-Ornithine L-Aspartate (LOLA) in Hepatic Encephalopathy. Kircheis G, Lüth S. Drugs; 2019 Feb 24; 79(Suppl 1):23-29. PubMed ID: 30706424 [Abstract] [Full Text] [Related]
17. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy. Mittal VV, Sharma BC, Sharma P, Sarin SK. Eur J Gastroenterol Hepatol; 2011 Aug 24; 23(8):725-32. PubMed ID: 21646910 [Abstract] [Full Text] [Related]